Akari Therapeutics, Plc (AKTX) Buy Target $2.05 Sell Target $2.28

Trade Setup

Buy Target $2.05
Sell Target $2.28

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases. 


X